DMRA
Galecto, Inc.
- Latest sale
- $7k
- Jul 6 · No plan
- Form 4 sales
- 17
- On record
- Form 144 notices
- 36
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleUnusualJan 3 2025
Sold 471 shares at $5.60 ($3k)
Winslow Garrett, General Counsel
No 10b5-1 planSold 31.8% of holdings ($8k position)1,009 shares leftFirst sale on recordFiling
- 2 Form 4 saleNo planJul 3 +181 days
Sold 147 shares at $3.39 ($498)
Firmani Lori, Interim CFO
No 10b5-1 planSold 17.5% of holdings ($3k position)692 shares leftFiling
- 3 Form 4 saleNo planJul 3 same day
Sold 260 shares at $3.39 ($881)
Winslow Garrett, General Counsel
No 10b5-1 planSold 15.4% of holdings ($6k position)1,429 shares leftFiling
- 4 Form 4 saleNo planJul 3 same day
Sold 735 shares at $3.38 ($2k)
Schambye Hans T., Chief Executive Officer
No 10b5-1 planSold 15.5% of holdings ($16k position)4,022 shares leftFiling
- 5 Form 4 saleNo planJan 2 +183 days
Sold 135 shares at $21.41 ($3k)
Firmani Lori, Chief Financial Officer
No 10b5-1 planSold 12.7% of holdings ($23k position)931 shares leftFiling
- 6 Form 4 saleNo planJan 2 same day
Sold 255 shares at $21.38 ($5k)
Winslow Garrett, General Counsel
No 10b5-1 planSold 12.1% of holdings ($45k position)1,854 shares leftFiling
- 7 Form 4 saleNo planJan 2 same day
Sold 700 shares at $21.38 ($15k)
Schambye Hans T., Chief Executive Officer
No 10b5-1 planSold 13% of holdings ($115k position)4,682 shares leftFiling
- 8 Form 4 saleNo planJul 6 +185 days
Sold 245 shares at $29.98 ($7k)
Winslow Garrett, General Counsel
No 10b5-1 planSold 9.7% of holdings ($76k position)2,289 shares left0.9x usual sizeFiling
Every transaction
Loading transactions…
Sales, notices and lockups (53)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | Winslow Garrett | General Counsel | Form 4 sale | 245 | $7k | 9.7% | No plan | SEC |
| Jan 2, 2026 | Schambye Hans T. | Chief Executive Officer | Form 4 sale | 700 | $15k | 13.0% | No plan | SEC |
| Jan 2, 2026 | Winslow Garrett | General Counsel | Form 4 sale | 255 | $5k | 12.1% | No plan | SEC |
| Jan 2, 2026 | Firmani Lori | Chief Financial Officer | Form 4 sale | 135 | $3k | 12.7% | No plan | SEC |
| Jul 3, 2025 | Schambye Hans T. | Chief Executive Officer | Form 4 sale | 735 | $2k | 15.5% | No plan | SEC |
| Jul 3, 2025 | Winslow Garrett | General Counsel | Form 4 sale | 260 | $881 | 15.4% | No plan | SEC |
| Jul 3, 2025 | Firmani Lori | Interim CFO | Form 4 sale | 147 | $498 | 17.5% | No plan | SEC |
| Jan 3, 2025 | Winslow Garrett | General Counsel | Form 4 sale | 471 | $3k | 31.8% | Unusual | SEC |
| Jan 3, 2025 | Firmani Lori | Interim CFO | Form 4 sale | 261 | $1k | 36.0% | Unusual | SEC |
| Jan 3, 2025 | Schambye Hans T. | Chief Executive Officer | Form 4 sale | 1,341 | $8k | 28.3% | Unusual | SEC |
| Oct 2, 2023 | Orbimed Capital LLC | Shareholder | Form 144 notice | 57,312 | $41k | Notice | SEC | |
| Oct 2, 2023 | OrbiMed Advisors Israel II Ltd | Shareholder | Form 144 notice | 244,527 | $176k | Notice | SEC | |
| Oct 2, 2023 | Orbimed Advisors LLC | Shareholder | Form 144 notice | 37,675 | $27k | Notice | SEC | |
| Oct 2, 2023 | Orbimed Advisors LLC | Shareholder | Form 144 notice | 585,274 | $421k | Notice | SEC | |
| Aug 30, 2023 | Orbimed Capital LLC | Shareholder | Form 144 notice | 119,679 | $69k | Notice | SEC | |
| Aug 30, 2023 | OrbiMed Advisors Israel II Ltd | Shareholder | Form 144 notice | 510,610 | $296k | Notice | SEC | |
| Aug 30, 2023 | Orbimed Advisors LLC | Shareholder | Form 144 notice | 78,659 | $46k | Notice | SEC | |
| Aug 30, 2023 | Orbimed Advisors LLC | Shareholder | Form 144 notice | 1.2M | $709k | Notice | SEC | |
| Aug 21, 2023 | Orbimed Advisors LLC | Shareholder | Form 144 notice | 1.5M | $932k | Notice | SEC | |
| Aug 21, 2023 | Orbimed Advisors LLC | Shareholder | Form 144 notice | 75,473 | $57k | Notice | SEC | |
| Aug 21, 2023 | Orbimed Capital LLC | Shareholder | Form 144 notice | 147,910 | $91k | Notice | SEC | |
| Aug 21, 2023 | OrbiMed Advisors Israel II Ltd | Shareholder | Form 144 notice | 631,048 | $389k | Notice | SEC | |
| Aug 15, 2023 | OrbiMed Advisors Israel II Ltd | 10% owner | Form 4 sale | 822,680 | $617k | 35.3% | Unusual | SEC |
| Aug 15, 2023 | Orbimed Capital LLC | Shareholder | Form 144 notice | 114,843 | $86k | Notice | SEC | |
| Aug 15, 2023 | OrbiMed Advisors Israel II Ltd | Shareholder | Form 144 notice | 489,970 | $367k | Notice | SEC | |
| Aug 15, 2023 | Orbimed Advisors LLC | Shareholder | Form 144 notice | 1.2M | $880k | Notice | SEC | |
| Aug 15, 2023 | Orbimed Advisors LLC | Shareholder | Form 144 notice | 75,473 | $57k | Notice | SEC | |
| Jul 31, 2023 | OrbiMed Capital GP VII LLC | 10% owner | Form 4 sale | 209,400 | $628k | 9.0% | No plan | SEC |
| Jul 31, 2023 | Orbimed Capital LLC | Shareholder | Form 144 notice | 246,830 | $745k | Notice | SEC | |
| Jul 31, 2023 | OrbiMed Advisors Israel II Ltd | Shareholder | Form 144 notice | 180,300 | $545k | Notice | SEC | |
| Jul 31, 2023 | Orbimed Advisors LLC | Shareholder | Form 144 notice | 930,717 | $2.8M | Notice | SEC | |
| Jul 31, 2023 | Orbimed Advisors LLC | Shareholder | Form 144 notice | 162,153 | $490k | Notice | SEC | |
| Jul 25, 2023 | OrbiMed Capital GP VII LLC | 10% owner | Form 4 sale | 39,200 | $114k | 1.7% | No plan | SEC |
| Jul 25, 2023 | Orbimed Capital LLC | Shareholder | Form 144 notice | 8,100 | $19k | Notice | SEC | |
| Jul 25, 2023 | OrbiMed Advisors Israel II Ltd | Shareholder | Form 144 notice | 4,700 | $11k | Notice | SEC | |
| Jul 25, 2023 | Orbimed Advisors LLC | Shareholder | Form 144 notice | 26,700 | $63k | Notice | SEC | |
| Jul 25, 2023 | Orbimed Advisors LLC | Shareholder | Form 144 notice | 7,800 | $18k | Notice | SEC | |
| Jul 13, 2023 | OrbiMed Advisors Israel II Ltd | 10% owner | Form 4 sale | 194,700 | $467k | 7.8% | No plan | SEC |
| Jul 13, 2023 | OrbiMed Advisors Israel II Ltd | Shareholder | Form 144 notice | 52,800 | $135k | Notice | SEC | |
| Jul 13, 2023 | Orbimed Capital LLC | Shareholder | Form 144 notice | 14,700 | $37k | Notice | SEC | |
| Jul 13, 2023 | Orbimed Advisors LLC | Shareholder | Form 144 notice | 132,100 | $337k | Notice | SEC | |
| Jul 13, 2023 | Orbimed Advisors LLC | Shareholder | Form 144 notice | 9,800 | $25k | Notice | SEC | |
| Apr 17, 2023 | Orbimed Advisors LLC | 10% owner | Form 4 sale | 68,481 | $128k | 2.8% | No plan | SEC |
| Apr 12, 2023 | OrbiMed Advisors Israel II Ltd | 10% owner | Form 4 sale | 67,537 | $121k | 2.7% | No plan | SEC |
| Apr 10, 2023 | Orbimed Advisors LLC | Shareholder | Form 144 notice | 1,686 | $3k | Notice | SEC | |
| Apr 10, 2023 | Orbimed Capital LLC | Shareholder | Form 144 notice | 2,512 | $5k | Notice | SEC | |
| Apr 10, 2023 | OrbiMed Advisors Israel II Ltd | Shareholder | Form 144 notice | 9,064 | $17k | Notice | SEC | |
| Apr 10, 2023 | Orbimed Advisors LLC | Shareholder | Form 144 notice | 22,638 | $43k | Notice | SEC | |
| Apr 6, 2023 | OrbiMed Genesis GP LLC | 10% owner | Form 4 sale | 102,630 | $222k | 3.9% | No plan | SEC |
| Apr 5, 2023 | OrbiMed Advisors Israel II Ltd | Shareholder | Form 144 notice | 43,810 | $98k | Notice | SEC | |
| Apr 5, 2023 | Orbimed Advisors LLC | Shareholder | Form 144 notice | 109,532 | $245k | Notice | SEC | |
| Apr 5, 2023 | Orbimed Capital LLC | Shareholder | Form 144 notice | 12,215 | $27k | Notice | SEC | |
| Apr 5, 2023 | Orbimed Advisors LLC | Shareholder | Form 144 notice | 8,143 | $18k | Notice | SEC |